Biblio

Export 136 results:
[ Author(Asc)] Title Type Year
Filters: First Letter Of Last Name is R  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
R
D. Renard, Collombier, L., Demattei, C., Wacongne, A., Charif, M., Ayrignac, X., Azakri, S., Gaillard, N., Boudousq, V., Lehmann, S., de Champfleur, N. Menjot, and Thouvenot, E., “Cerebrospinal Fluid, MRI, and Florbetaben-PET in Cerebral Amyloid Angiopathy-Related Inflammation.”, J Alzheimers Dis, vol. 61, no. 3, pp. 1107-1117, 2018.
D. Ren, Lopez, O. L., Lingler, J. H., and Conley, Y., “Association Between the APOEɛ2/ɛ4 Genotype and Alzheimer's Disease and Mild Cognitive Impairment Among African Americans.”, J Alzheimers Dis, vol. 81, no. 3, pp. 943-948, 2021.
P. Ren, Lo, R. Y., Chapman, B. P., Mapstone, M., Porsteinsson, A., and Lin, F., “Longitudinal Alteration of Intrinsic Brain Activity in the Striatum in Mild Cognitive Impairment.”, J Alzheimers Dis, vol. 54, no. 1, pp. 69-78, 2016.
R. Remington, Bechtel, C., Larsen, D., Samar, A., Doshanjh, L., Fishman, P., Luo, Y., Smyers, K., Page, R., Morrell, C., and Shea, T. B., “A Phase II Randomized Clinical Trial of a Nutritional Formulation for Cognition and Mood in Alzheimer's Disease.”, J Alzheimers Dis, 2015.
R. Remington, Bechtel, C., Larsen, D., Samar, A., Page, R., Morrell, C., and Shea, T. B., “Maintenance of Cognitive Performance and Mood for Individuals with Alzheimer's Disease Following Consumption of a Nutraceutical Formulation: A One-Year, Open-Label Study.”, J Alzheimers Dis, vol. 51, no. 4, pp. 991-5, 2016.
K. Reiter, Nielson, K. A., Durgerian, S., Woodard, J. L., J Smith, C., Seidenberg, M., Kelly, D. A., and Rao, S. M., “Five-Year Longitudinal Brain Volume Change in Healthy Elders at Genetic Risk for Alzheimer's Disease.”, J Alzheimers Dis, vol. 55, no. 4, pp. 1363-1377, 2017.
B. Reisberg, Torossian, C., Shulman, M. B., Monteiro, I., Boksay, I., Golomb, J., Benarous, F. Guillo, Ulysse, A., Oo, T., Vedvyas, A., Rao, J. A., Marsh, K., Kluger, A., Sangha, J., Hassan, M., Alshalabi, M., Arain, F., Shaikh, N., Buj, M., Kenowsky, S., Masurkar, A. V., Rabin, L., Noroozian, M., Sánchez-Saudinós, M. A. Belén, Blesa, R., Auer, S., Zhang, Y., de Leon, M., Sadowski, M., Wisniewski, T., Gauthier, S., and Shao, Y., “Two Year Outcomes, Cognitive and Behavioral Markers of Decline in Healthy, Cognitively Normal Older Persons with Global Deterioration Scale Stage 2 (Subjective Cognitive Decline with Impairment).”, J Alzheimers Dis, vol. 67, no. 2, pp. 685-705, 2019.
J. Reimand, Groot, C., Teunissen, C. E., Windhorst, A. D., Boellaard, R., Barkhof, F., Nazarenko, S., van der Flier, W. M., van Berckel, B. N. M., Scheltens, P., Ossenkoppele, R., and Bouwman, F., “Why Is Amyloid-β PET Requested After Performing Cerebrospinal Fluid Biomarkers?”, J Alzheimers Dis, vol. 73, no. 2, pp. 559-569, 2019.
B. L. R. Reijs, Vos, S. J. B., Soininen, H., Lötjönen, J., Koikkalainen, J., Pikkarainen, M., Hall, A., Vanninen, R., Liu, Y., Herukka, S. - K., Freund-Levi, Y., Frisoni, G. B., Frölich, L., Nobili, F., Rikkert, M. Olde, Spiru, L., Tsolaki, M., Wallin, A. K., Scheltens, P., Verhey, F., and Visser, P. Jelle, “Association Between Later Life Lifestyle Factors and Alzheimer's Disease Biomarkers in Non-Demented Individuals: A Longitudinal Descriptive Cohort Study.”, J Alzheimers Dis, vol. 60, no. 4, pp. 1387-1395, 2017.
B. L. R. Reijs, Ramakers, I. H. G. B., Köhler, S., Teunissen, C. E., Koel-Simmelink, M., Nathan, P. J., Tsolaki, M., Wahlund, L. - O., Waldemar, G., Hausner, L., Vandenberghe, R., Johannsen, P., Blackwell, A., Vanderstichele, H., Verhey, F., and Visser, P. Jelle, “Memory Correlates of Alzheimer's Disease Cerebrospinal Fluid Markers: A Longitudinal Cohort Study.”, J Alzheimers Dis, vol. 60, no. 3, pp. 1119-1128, 2017.
B. L. R. Reijs, Ramakers, I. H. G. B., Elias-Sonnenschein, L., Teunissen, C. E., Koel-Simmelink, M., Tsolaki, M., Wahlund, L. - O., Waldemar, G., Hausner, L., Johannsen, P., Vanderstichele, H., Verhey, F., Devanand, D. P., and Visser, P. Jelle, “Relation of Odor Identification with Alzheimer's Disease Markers in Cerebrospinal Fluid and Cognition.”, J Alzheimers Dis, vol. 60, no. 3, pp. 1025-1034, 2017.
Â. Rego, Viana, S. D., Ribeiro, C. A. Fontes, Rodrigues-Santos, P., and Pereira, F. C., “Monophosphoryl Lipid-A: A Promising Tool for Alzheimer's Disease Toll.”, J Alzheimers Dis, vol. 52, no. 4, pp. 1189-202, 2016.
C. Reed, Happich, M., Argimon, J. Maria, Haro, J. Maria, Wimo, A., Bruno, G., Dodel, R., Jones, R. W., Vellas, B., and Belger, M., “What Drives Country Differences in Cost of Alzheimer's Disease? An Explanation from Resource Use in the GERAS Study.”, J Alzheimers Dis, vol. 57, no. 3, pp. 797-812, 2017.
M. R. Redston, Hilmer, S. N., McLachlan, A. J., Clough, A. J., and Gnjidic, D., “Prevalence of Potentially Inappropriate Medication Use in Older Inpatients with and without Cognitive Impairment: A Systematic Review.”, J Alzheimers Dis, vol. 61, no. 4, pp. 1639-1652, 2018.
H. P Reddy, “A Critical Assessment of Research on Neurotransmitters in Alzheimer's Disease.”, J Alzheimers Dis, vol. 57, no. 4, pp. 969-974, 2017.
H. P Reddy, Manczak, M., Yin, X. L., Grady, M. Catherine, Mitchell, A., Tonk, S., Kuruva, C. Sekhar, Bhatti, J. Singh, Kandimalla, R., Vijayan, M., Kumar, S., Wang, R., Pradeepkiran, J. Adi, Ogunmokun, G., Thamarai, K., Quesada, K., Boles, A., and Reddy, A. P., “Protective Effects of Indian Spice Curcumin Against Amyloid-β in Alzheimer's Disease.”, J Alzheimers Dis, vol. 61, no. 3, pp. 843-866, 2018.
H. P Reddy, Manczak, M., and Yin, X. L., “Mitochondria-Division Inhibitor 1 Protects Against Amyloid-β induced Mitochondrial Fragmentation and Synaptic Damage in Alzheimer's Disease.”, J Alzheimers Dis, vol. 58, no. 1, pp. 147-162, 2017.
H. P Reddy, Manczak, M., Yin, X. L., and Reddy, A. P., “Synergistic Protective Effects of Mitochondrial Division Inhibitor 1 and Mitochondria-Targeted Small Peptide SS31 in Alzheimer's Disease.”, J Alzheimers Dis, vol. 62, no. 4, pp. 1549-1565, 2018.
V. Redaelli, Salsano, E., Colleoni, L., Corbetta, P., Tringali, G., Del Sole, A., Giaccone, G., and Rossi, G., “Frontotemporal Dementia and Chorea Associated with a Compound Heterozygous TREM2 Mutation.”, J Alzheimers Dis, vol. 63, no. 1, pp. 195-201, 2018.
G. W. Rebok, Ball, K., Guey, L. T., Jones, R. N., Kim, H. - Y., King, J. W., Marsiske, M., Morris, J. N., Tennstedt, S. L., Unverzagt, F. W., and Willis, S. L., “Ten-year effects of the advanced cognitive training for independent and vital elderly cognitive training trial on cognition and everyday functioning in older adults.”, J Am Geriatr Soc, vol. 62, no. 1, pp. 16-24, 2014.
M. Reale, D'Angelo, C., Costantini, E., Di Nicola, M., Yarla, N. Sastry, Kamal, M. Amjad, Salvador, N., and Perry, G., “Expression Profiling of Cytokine, Cholinergic Markers, and Amyloid-β Deposition in the APPSWE/PS1dE9 Mouse Model of Alzheimer's Disease Pathology.”, J Alzheimers Dis, vol. 62, no. 1, pp. 467-476, 2018.
I. Rawtaer, Gao, Q., Nyunt, M. Shwe Zin, Feng, L., Chong, M. Sian, Lim, W. Shiong, Lee, T. - S., Yap, P., Yap, K. Bee, and Ng, T. Pin, “Psychosocial Risk and Protective Factors and Incident Mild Cognitive Impairment and Dementia in Community Dwelling Elderly: Findings from the Singapore Longitudinal Ageing Study.”, J Alzheimers Dis, vol. 57, no. 2, pp. 603-611, 2017.
R. Ravona-Springer, Schnaider-Beeri, M., and Goldbourt, U., “Triceps and Subscapular Skinfold in Men Aged 40-65 and Dementia Prevalence 36 Years Later.”, J Alzheimers Dis, vol. 57, no. 3, pp. 873-883, 2017.
A. Raunio, Myllykangas, L., Kero, M., Polvikoski, T., Paetau, A., and Oinas, M., “Amygdala α-Synuclein Pathology in the Population-Based Vantaa 85+ Study.”, J Alzheimers Dis, vol. 58, no. 3, pp. 669-674, 2017.
B. - S. Rauchmann, Sadlon, A., and Perneczky, R., “Soluble TREM2 and Inflammatory Proteins in Alzheimer's Disease Cerebrospinal Fluid.”, J Alzheimers Dis, vol. 73, no. 4, pp. 1615-1626, 2020.

Pages